Hibiscus sabdariffa extract inhibits the development of atherosclerosis in cholesterol-fed rabbits
- PMID: 12926900
- DOI: 10.1021/jf030065w
Hibiscus sabdariffa extract inhibits the development of atherosclerosis in cholesterol-fed rabbits
Abstract
Hibiscus sabdariffa L., a local soft drink material and medicinal herb, is usually used effectively in native medicines against hypertension, pyrexia, and liver disorders. Here, we report an extract, HSE (H. sabdariffa extract), which is designed to exhibit hypolipidemia and antiatherosclerotic effects in rabbits with experimental atherosclerosis. New Zealand White rabbits were fed with a normal diet, high cholesterol (1.3%), lard oil (3%) diet (HCD) with or without 0.5 or 1% HSE for 10 weeks. The levels of triglyceride, cholesterol, and low-density lipoprotein cholesterol (LDL-C) were lower in the serum of rabbits fed HCD plus HSE than in the serum of rabbits fed HCD. Feeding HSE (0.5 and 1% in the diet) to rabbits significantly reduced severe atherosclerosis in the aorta. Histopathological examination showed that HSE reduced foam cell formation and inhibited smooth muscle cell migration and calcification in the blood vessel of rabbits. These results suggest that HSE inhibits serum lipids and shows an antiatherosclerotic activity.
Similar articles
-
Hibiscus sabdariffa ethanolic extract protects against dyslipidemia and oxidative stress induced by chronic cholesterol administration in rabbits.Afr J Med Med Sci. 2010 Dec;39 Suppl:161-70. Afr J Med Med Sci. 2010. PMID: 22416659
-
Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits.Atherosclerosis. 1999 Jan;142(1):139-49. doi: 10.1016/s0021-9150(98)00230-5. Atherosclerosis. 1999. PMID: 9920515
-
Hypolipidemic and antioxidant effects of ethanolic extract from dried calyx of Hibiscus sabdariffa in alloxan-induced diabetic rats.Fundam Clin Pharmacol. 2007 Dec;21(6):601-9. doi: 10.1111/j.1472-8206.2007.00525.x. Fundam Clin Pharmacol. 2007. PMID: 18034661
-
Chemopreventive properties and molecular mechanisms of the bioactive compounds in Hibiscus sabdariffa Linne.Curr Med Chem. 2011;18(8):1245-54. doi: 10.2174/092986711795029663. Curr Med Chem. 2011. PMID: 21291361 Review.
-
[Therapeutic potential of Hibiscus sabdariffa: a review of the scientific evidence].Endocrinol Nutr. 2014 May;61(5):274-95. doi: 10.1016/j.endonu.2013.10.012. Epub 2014 Jan 17. Endocrinol Nutr. 2014. PMID: 24444676 Review. Spanish.
Cited by
-
Effects of Hibiscus sabdariffa supplementation on metabolism and bladder in obese rats.Acta Cir Bras. 2024 Sep 9;39:e395024. doi: 10.1590/acb395024. eCollection 2024. Acta Cir Bras. 2024. PMID: 39258617 Free PMC article.
-
Toxicity and immunomodulatory activity of fractions of Hibiscus sabdariffa Linn (family Malvaceae) in animal models.Afr J Tradit Complement Altern Med. 2008 Jun 18;5(4):394-8. Afr J Tradit Complement Altern Med. 2008. PMID: 20161963 Free PMC article.
-
Action Mechanism of Rosella (Hibiscus sabdariffa L.) Used to Treat Metabolic Syndrome in Elderly Women.Evid Based Complement Alternat Med. 2020 Sep 14;2020:5351318. doi: 10.1155/2020/5351318. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 33005201 Free PMC article.
-
Development of a Mucoadhesive and an in Situ Gelling Formulation Based on κ-Carrageenan for Application on Oral Mucosa and Esophagus Walls. II. Loading of a Bioactive Hydroalcoholic Extract.Mar Drugs. 2019 Mar 5;17(3):153. doi: 10.3390/md17030153. Mar Drugs. 2019. PMID: 30841540 Free PMC article.
-
Hibiscus sabdariffa L., roselle calyx, from ethnobotany to pharmacology.J Exp Pharmacol. 2012 Feb 28;4:25-39. doi: 10.2147/JEP.S27974. eCollection 2012. J Exp Pharmacol. 2012. PMID: 27186114 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources